ALLO
Allogene Therapeutics Poised to Revolutionize Cell Therapy with Scalable, Accessible, and Deliverable CAR T Solutions
Allogene Therapeutics, a leading biotechnology company, has made significant strides in the field of cell therapy, particularly in the development of allogeneic CAR T solutions. According to its Q4 2025 conference call transcript, the company is on track to deliver meaningful clinical milestones with rigor and speed in 2026. The